{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:56:04Z","timestamp":1792299364973,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11596-017-1737-5","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:04:24Z","timestamp":1515449064000},"page":"337-342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy"],"prefix":"10.1007","volume":"37","author":[{"given":"Yogendranathsing","family":"Unmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ishraq","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"issue":"5","key":"1737_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncpendmet0142","volume":"2","author":"A Vinik","year":"2006","unstructured":"Vinik A, Ullal J, Parson HK, et al. Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab, 2006,2(5):269\u2013281","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"1737_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.diabres.2011.11.013","volume":"96","author":"SC Smith","year":"2012","unstructured":"Smith SC, Lamping DL, Maclaine GD. Measuring healthrelated quality of life in diabetic peripheral neuropathy: a systematic review. Diabetes Res Clin Pract, 2012,96(3):261\u2013270","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1737_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(99)00112-6","volume":"47","author":"BS Galer","year":"2000","unstructured":"Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract, 2000,47(2):123\u2013128","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1737_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1534734614521235","volume":"13","author":"A Wang","year":"2014","unstructured":"Wang A, Xu Z, Mu Y, et al. Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in China. Int J Low Extrem Wounds, 2014,13(1):17\u201321","journal-title":"Int J Low Extrem Wounds"},{"issue":"2","key":"1737_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8227(01)00278-9","volume":"54","author":"D Olaleye","year":"2001","unstructured":"Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract, 2001,54(2):115\u2013128","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"1737_CR6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","volume":"27","author":"PJ Dyck","year":"2011","unstructured":"Dyck PJ, Albers JW, Andersen H, et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev, 2011,27(7):620\u2013628","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"1737_CR7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/dia.2006.8.654","volume":"8","author":"AI Vinik","year":"2006","unstructured":"Vinik AI, Kong X, Megerian JT, et al. Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol Ther, 2006,8(6):654\u2013662","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"1737_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","volume":"24","author":"BA Perkins","year":"2001","unstructured":"Perkins BA, Olaleye D, Zinman B, et al. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care, 2001,24(2):250\u2013256","journal-title":"Diabetes Care"},{"issue":"1","key":"1737_CR9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.dsx.2013.02.003","volume":"8","author":"G Hussain","year":"2014","unstructured":"Hussain G, Rizvi SA, Singhal S, et al. Cross sectional study to evaluate the of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy. Diabetes Metab Syndr, 2014,8(1):48\u201352","journal-title":"Diabetes Metab Syndr"},{"key":"1737_CR10","doi-asserted-by":"crossref","unstructured":"Meijer JW, Smit AJ, Lefrandt JD, et al. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care, 2005,28(9):2201\u20132205","DOI":"10.2337\/diacare.28.9.2201"},{"issue":"10","key":"1737_CR11","first-page":"933","volume":"10","author":"P Valensi","year":"1993","unstructured":"Valensi P, Attali JR, Gagant S. Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy. Diabet Med, 1993,10(10):933\u2013939","journal-title":"The French Group for Research and Study of Diabetic Neuropathy. Diabet Med"},{"issue":"6","key":"1737_CR12","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","volume":"27","author":"AJM Boulton","year":"2004","unstructured":"Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care, 2004,27(6):1458\u20131486","journal-title":"Diabetes Care"},{"issue":"3","key":"1737_CR13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diacare.26.3.697","volume":"26","author":"JW Meijer","year":"2003","unstructured":"Meijer JW, Bosma E, Lefrandt JD, et al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care, 2003, 26(3):697\u2013701","journal-title":"Diabetes Care"},{"issue":"4","key":"1737_CR14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJM Boulton","year":"2005","unstructured":"Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care, 2005,28(4):956\u2013962","journal-title":"Diabetes Care"},{"issue":"2","key":"1737_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","volume":"42","author":"PJ Dyck","year":"2010","unstructured":"Dyck PJ, Overland CJ, Low PA, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve, 2010,42(2):157\u2013164","journal-title":"NPhys trial. Muscle Nerve"},{"issue":"2","key":"1737_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004150050182","volume":"245","author":"P Bertora","year":"1998","unstructured":"Bertora P, Valla P, Dezuanni E, et al. Prevalence of subclinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution within motor and sensory nerve fibres. J Neurol, 1998,245(2):81\u201386","journal-title":"J Neurol"},{"issue":"5","key":"1737_CR17","first-page":"433","volume":"21","author":"DH Akbar","year":"2000","unstructured":"Akbar DH, Mira SA, Zawawi TH, et al. Subclinical diabetic neuropathy: a common complication in Saudi diabetics. Saudi Med J, 2000,21(5):433\u2013437","journal-title":"Saudi Med J"},{"key":"1737_CR18","first-page":"313","volume":"11","author":"S Popescu","year":"2016","unstructured":"Popescu S, Timar B, Baderca, et al. Age as an independent factor for the development of neuropathy in diabetic patients. Clin Interv Aging, 2016,11:313\u2013318","journal-title":"Clin Interv Aging"},{"issue":"1\u20132","key":"1737_CR19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1900\/RDS.2015.12.48","volume":"12","author":"N Papanas","year":"2015","unstructured":"Papanas N, Ziegler D. Risk factors and comorbidities in diabetic neuropathy: An update 2015. Rev Diabet Stud, 2015,12(1\u20132):48\u201362","journal-title":"Rev Diabet Stud"},{"issue":"7","key":"1737_CR20","first-page":"1162","volume":"20","author":"AI Adler","year":"1997","unstructured":"Adler AI, Boyko EJ, Ahroni JH, et al. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care, 1997,20(7):1162\u20131167","journal-title":"Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care"},{"issue":"11","key":"1737_CR21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s001250050586","volume":"39","author":"S Tesfaye","year":"1996","unstructured":"Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia, 1996,39(11):1377\u20131384","journal-title":"Diabetologia"},{"issue":"2","key":"1737_CR22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8227(98)00100-4","volume":"42","author":"JE Shaw","year":"1998","unstructured":"Shaw JE, Hodge AM, de Courten M, et al. Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes Res Clin Pract, 1998,42(2):131\u2013139","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"1737_CR23","first-page":"1263","volume":"41","author":"J Cabezas-Cerrato","year":"1998","unstructured":"Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia, 1998,41(11):1263\u20131269","journal-title":"Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia"},{"issue":"2","key":"1737_CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","volume":"36","author":"MJ Young","year":"1993","unstructured":"Young MJ, Boulton AJ, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 1993,36(2):150\u2013154","journal-title":"Diabetologia"},{"issue":"6","key":"1737_CR25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jdi.12223","volume":"5","author":"D Bansal","year":"2014","unstructured":"Bansal D, Gudala K, Muthyala H, et al. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig, 2014, 5(6):714\u2013721","journal-title":"J Diabetes Investig"},{"issue":"1","key":"1737_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNP.0b013e3182051334","volume":"28","author":"T Erbas","year":"2011","unstructured":"Erbas T, Ertas M, Yucel A, et al. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients. J Clin Neurophysiol, 2011,28(1):51\u201355","journal-title":"J Clin Neurophysiol"},{"issue":"3","key":"1737_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diabres.2010.02.002","volume":"88","author":"B Lu","year":"2010","unstructured":"Lu B, Yang Z, Wang M, et al. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract, 2010, 88(3):289\u2013294","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"1737_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-122-8-199504150-00001","volume":"122","author":"The Diabetes ControlComplications Trial Research Group.","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med, 1995,122(8):561\u2013568","journal-title":"Ann Intern Med"},{"issue":"2","key":"1737_CR29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009,360(2):129\u2013139","journal-title":"N Engl J Med"},{"issue":"9739","key":"1737_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet, 2010,376(9739):419\u2013430","journal-title":"Lancet"},{"issue":"15","key":"1737_CR31","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, et al. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008,359(15):1577\u20131589","journal-title":"N Engl J Med"},{"issue":"3","key":"1737_CR32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","volume":"31","author":"D Ziegler","year":"2008","unstructured":"Ziegler D, Rathmann W, Dickhaus T, et al. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3. Diabetes Care, 2008,31(3):464\u2013469","journal-title":"Diabetes Care"},{"issue":"4","key":"1737_CR33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1474515114565215","volume":"15","author":"J Ybarra-Munoz","year":"2016","unstructured":"Ybarra-Munoz J, Jurado-Campos J, Garcia-Gil M, et al. Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study. Eur J Cardiovasc Nurs, 2016,15(4):248\u2013254","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"4","key":"1737_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med, 2005, 352(4):341\u2013350","journal-title":"N Engl J Med"},{"issue":"1","key":"1737_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0973-3930.60004","volume":"30","author":"K Morkrid","year":"2010","unstructured":"Morkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries, 2010,30(1):11\u201317","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"1","key":"1737_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-5996-4-21","volume":"4","author":"P Katulanda","year":"2012","unstructured":"Katulanda P, Ranasinghe P, Jayawardena R, et al. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr, 2012,4(1):21","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"1737_CR37","doi-asserted-by":"crossref","first-page":"e61053","DOI":"10.1371\/journal.pone.0061053","volume":"8","author":"B Lu","year":"2013","unstructured":"Lu B, Hu J, Wen J, et al. Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes -ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS One, 2013,8(4): e61053","journal-title":"PLoS One"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-017-1737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-017-1737-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-017-1737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T04:09:52Z","timestamp":1570594192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-017-1737-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1737"],"URL":"https:\/\/doi.org\/10.1007\/s11596-017-1737-5","relation":{},"ISSN":["1672-0733"],"issn-type":[{"value":"1672-0733","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}